Treatment for Vitamin D3 Deficiency
For adults with vitamin D deficiency, treat with 50,000 IU of vitamin D2 or D3 once weekly for 8 weeks (or 6,000 IU daily as equivalent), followed by maintenance therapy of 1,500-2,000 IU daily. 1
Treatment Approach by Age Group
Adults (Age 19+)
The Endocrine Society guideline provides the most authoritative treatment algorithm 1:
- Loading phase: 50,000 IU weekly for 8 weeks OR 6,000 IU daily
- Target: Achieve 25(OH)D level above 30 ng/mL (75 nmol/L)
- Maintenance: 1,500-2,000 IU daily thereafter
This regimen is supported by the most recent systematic review showing that large bolus doses (50,000 IU weekly for 8 weeks) followed by monthly or bimonthly maintenance of 50,000 IU optimally corrects and maintains vitamin D levels 2.
Children and Adolescents
For children 1-18 years 1:
- Loading phase: 2,000 IU daily for at least 6 weeks OR 50,000 IU once weekly for 6 weeks
- Target: 25(OH)D above 30 ng/mL
- Maintenance: 600-1,000 IU daily
- Critical addition: Always add oral calcium 500 mg daily during treatment 3
For infants 0-1 year 1:
- Loading phase: 2,000 IU daily OR 50,000 IU once weekly for 6 weeks
- Maintenance: 400-1,000 IU daily
Recent evidence confirms that daily dosing (2,000-4,000 IU) is equally effective as fortnightly bolus dosing in children, with both achieving sufficiency by 12 weeks 4.
Special Populations Requiring Higher Doses
Obese patients, malabsorption syndromes, or those on medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids, ketoconazole, AIDS medications) 1:
- Loading phase: 6,000-10,000 IU daily (2-3 times standard dose)
- Maintenance: 3,000-6,000 IU daily
This higher dosing is essential because these patients have significantly impaired vitamin D absorption or metabolism 1.
Formulation Choice
Either vitamin D2 (ergocalciferol) or vitamin D3 (cholecalciferol) can be used 1, though vitamin D3 is increasingly preferred due to superior pharmacological characteristics and longer duration of action 5.
Monitoring Strategy
- Check serum calcium (adjusted for albumin) 1 month after completing loading regimen to unmask potential primary hyperparathyroidism
- Recheck 25(OH)D level only if symptomatic deficiency, malabsorption present, or poor compliance suspected
- Routine monitoring during maintenance is unnecessary given vitamin D's large therapeutic index 7
For high-risk scenarios 1:
- Patients with extrarenal production of 1,25(OH)2D: Monitor both 25(OH)D and calcium serially to prevent hypercalcemia
- Primary hyperparathyroidism with vitamin D deficiency: Monitor calcium levels during treatment
Critical Caveats
Calcium co-supplementation is essential in children: Studies demonstrate that combined calcium (500 mg daily) plus vitamin D achieves 50-61% complete healing versus only 15-19% with vitamin D alone in nutritional rickets 3. This principle applies to all pediatric vitamin D deficiency treatment.
Oral route is superior to intramuscular: Oral administration more rapidly restores 25(OH)D levels than IM injections, with peak levels at 30 days (oral) versus 120 days (IM) 3.
Safety profile: Both daily and bolus regimens can cause transient asymptomatic hypercalcemia (34-51% of cases) and occasional hypercalciuria (5.7%), which resolve spontaneously 4. One case report noted a 25(OH)D level of 263 nmol/L with normal calcium using stoss protocol, demonstrating the wide therapeutic window 8.
Upper limits without medical supervision 1:
- Adults and children >8 years: 4,000 IU daily
- However, up to 10,000 IU daily may be needed to correct deficiency in adults
Target Levels
The consensus target is 25(OH)D >30 ng/mL (75 nmol/L) for optimal bone health and muscle function 1, 6. While 20 ng/mL may suffice for general population, maintaining levels above 30 ng/mL is recommended for at-risk categories 7. Recent evidence suggests concentrations between 40-70 ng/mL may provide greater protection against adverse health outcomes, achievable with 4,000-6,000 IU daily 9.